“a favorable trend”

Although we failed to show a statistically significant reduction in alcohol use, we did show a favorable trend, and reduction in alcohol use was not the primary outcome of this small proof-of-concept pilot trial.

While the majority of meta-analyses, incorporating data from both non-randomized controlled trials (non-RCTs) and RCTs, indicated a favorable trend toward lower complication rates with minimally invasive surgery (MIS), it is noteworthy that a singular study did not detect a significant difference between MIS and open liver resection.

For patients with diabetes mellitus, our analysis suggests a favorable trend concerning the effect of 25(OH)D on eGFR and UACR without significant differences.

Although in-hospital mortality was not significantly lower in the remdesivir group, a favorable trend emerged in the 2023 cohort, suggesting a potential synergistic effect between remdesivir, early intervention, and improved supportive care [ 11 - 13 ].

Mean lean body mass showed a favorable trend of increment at week 6 (Δ 0.05 kg, 95% CI: −0.40, 0.49) and week 12 (Δ 0.16 kg, 95% CI: −0.33, 0.64) as compared to baseline in the intervention group but not in the control group which manifested decreasing lean body mass.

In contrast, manual rater thresholds exhibited a favorable trend for accuracy but not for specificity and sensitivity, likely influenced by poor inter-rater agreement. 4.4.2 Revised post hoc validation Consequently, we transitioned to a more focused validation method, as elaborated in the second stage of our process, providing a more targeted validation approach. indicating some variability in their assessments, yet demonstrating a generally consistent agreement with AIDAqc.

2 A), high TMEM71 expression was associated with significantly worse prognosis in multiple tumors, while it showed a favorable trend in some cancer types.

Questionnaire Outcomes No significant changes in questionnaire outcomes were found over time ( Table 5 ), although the PSQI results showed a favorable trend toward better sleep quality.

Therefore, although the observed change may indicate a favorable trend in physical performance, its clinical relevance should be interpreted with caution.

Following the intervention, a favorable trend was observed across multiple lipid parameters.

The trial enrolled 804 patients, and on final analysis for primary end point (efficacy boundary survival), the results showed a favorable trend, but no statistically significant benefit for pembrolizumab arm HR 0.83 (05% CI, 0.68–1.03).

This study observed a favorable trend of QOL improvement in the intervention group compared to the control group; however, no significant improvement was observed.

S5 and S6, showing a favorable trend in most domains.

Our findings contribute to this body of evidence, emphasizing that patients can achieve meaningful reductions in opioid use over time—highlighting a favorable trend in opioid stewardship and post-operative pain management strategies.

The main findings of our analysis were: (1) the number of patients with resolution of symptoms was not significantly different between groups; (2) recovery and symptom alleviation rates showed a favorable trend in patients receiving 3CL protease inhibitors compared to placebo; (3) 3CL protease inhibitors significantly reduced the viral load from baseline as compared with placebo and (4) were associated with higher risk of any adverse events (40.24% vs. 31.26%).

Experimentally, we observed that when s is a multiple of the batch size b , the accuracy maintains a favorable trend.

Subgroup analysis showed benefit with CTLA-4 inhibitors (HR = 0.75; 95 % CI: 0.64-0.89; I 2 = 66 %) and a favorable trend with PD-1 inhibitors (HR = 0.72; 95 % CI: 0.51-1.03; I 2 = 87 %), though not statistically significant.

The median RFS was 21.7 months in the CY+ group and 30.6 months in the CY− group, showing a favorable trend in the CY− group but no statistically significant difference ( p = 0.357) (Figure 2A ).

A log-rank test indicated a borderline statistical significance ( p = 0.058) in the survival distributions among the different DDD adherence, with the lower dose group showing a favorable trend.

However, since almost all the studies tended to show a favorable trend, it seems reasonable to conclude that combination therapy of AT and rTM for the treatment of patients with septic DIC might be superior to monotherapy.

The yearly survival rates of the patients, along with the appropriateness of prescriptions and DDDs of polymyxins exhibiting a favorable trend, are depicted in Figure 1 .

NCCN DT and PHQ-4 scores were comparable at baseline between the two groups, but they showed a favorable trend for patients with molecular alterations over time (NCCN DT at T1 3.3 vs 5; at T2 2.7 vs 4.5; at T3 3.7 vs 4.5; PHQ-4 at T1 2.3 vs 4.1; at T2 1.7 vs 3.6; at T3 2.2 vs 3.6).

The trial demonstrated significant benefits of MMAE adjunct with surgery at 6 months, a favorable trend with MMAE in nonsurgical management and a significant treatment effect for MMAE in patients aged ≥75 years undergoing surgery.

Clinical trials assessing MSC therapy in ARDS have shown that MSCs have been associated with a favorable trend in morality reduction, pulmonary function improvement, and cytokine correction ( 36 ).

Many retrospective studies conducted among cancer patients upon treatment of local anesthetics including lidocaine and ropivacaine demonstrate a favorable trend of decrease in tumor metastasis and recurrence.